CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 72 filers reported holding CYTOSORBENTS CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $420,000 | +677.8% | 131,655 | +912.5% | 0.06% | +700.0% |
| Q4 2021 | $54,000 | -90.8% | 13,003 | -82.9% | 0.01% | -95.2% |
| Q1 2020 | $586,000 | +134.4% | 75,869 | +16.8% | 0.15% | +406.9% |
| Q4 2019 | $250,000 | +51.5% | 64,970 | +98.0% | 0.03% | +31.8% |
| Q3 2019 | $165,000 | +28.9% | 32,820 | +94.4% | 0.02% | +69.2% |
| Q1 2019 | $128,000 | – | 16,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,126,300 | $8,706,000 | 1.93% |
| Sargent Investment Group, LLC | 471,755 | $3,647,000 | 1.68% |
| Manatuck Hill Partners, LLC | 125,000 | $966,000 | 0.89% |
| Soleus Capital Management, L.P. | 69,600 | $538,000 | 0.63% |
| EAM Investors, LLC | 136,098 | $1,052,000 | 0.33% |
| Granahan Investment Management | 691,130 | $5,342,000 | 0.29% |
| EAM Global Investors LLC | 61,795 | $478,000 | 0.28% |
| Winning Points Advisors, LLC | 35,000 | $269,000 | 0.26% |
| Leap Investments LP | 14,200 | $110,000 | 0.16% |
| Avenir Corp | 150,600 | $1,164,000 | 0.16% |